Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.
(2016) In Diabetes 65(1). p.239-254- Abstract
- Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with extrapancreatic effects beyond glycemic control. Here we demonstrate unexpected effects of GIP signaling in the vasculature. GIP induces the expression of the pro-atherogenic cytokine osteopontin (OPN) in mouse arteries, via local release of endothelin-1 (ET-1) and activation of cAMP response element binding protein (CREB). Infusion of GIP increases plasma OPN levels in healthy individuals. Plasma ET-1 and OPN levels are positively correlated in patients with critical limb ischemia. Fasting GIP levels are higher in individuals with a history of cardiovascular disease (myocardial infarction, stroke) when compared to controls. GIP receptor (GIPR) and OPN mRNA... (More)
- Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with extrapancreatic effects beyond glycemic control. Here we demonstrate unexpected effects of GIP signaling in the vasculature. GIP induces the expression of the pro-atherogenic cytokine osteopontin (OPN) in mouse arteries, via local release of endothelin-1 (ET-1) and activation of cAMP response element binding protein (CREB). Infusion of GIP increases plasma OPN levels in healthy individuals. Plasma ET-1 and OPN levels are positively correlated in patients with critical limb ischemia. Fasting GIP levels are higher in individuals with a history of cardiovascular disease (myocardial infarction, stroke) when compared to controls. GIP receptor (GIPR) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (stroke, transient ischemic attacks, amaurosis fugax) than in asymptomatic patients; and expression associates to parameters characteristic of unstable and inflammatory plaques (increased lipid accumulation, macrophage infiltration and reduced smooth muscle cell content). While GIPR expression is predominantly endothelial in healthy arteries from human, mouse, rat and pig; remarkable up-regulation is observed in endothelial and smooth muscle cells upon culture conditions yielding a "vascular disease-like" phenotype. Moreover, a common variant rs10423928 in the GIPR gene associated with increased risk of stroke in type 2 diabetes patients. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8035204
- author
- organization
-
- EXODIAB: Excellence of Diabetes Research in Sweden
- EpiHealth: Epidemiology for Health
- Diabetic Complications (research group)
- Translational Muscle Research (research group)
- Cardiovascular Research - Immunity and Atherosclerosis (research group)
- Cardiovascular Research - Hypertension (research group)
- Diabetes - Cardiovascular Disease (research group)
- Internal Medicine - Epidemiology (research group)
- Vascular Diseases - Clinical Research (research group)
- Cardiovascular Research - Translational Studies (research group)
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Diabetes
- volume
- 65
- issue
- 1
- pages
- 239 - 254
- publisher
- American Diabetes Association Inc.
- external identifiers
-
- pmid:26395740
- wos:000367424900026
- scopus:84962187932
- pmid:26395740
- ISSN
- 1939-327X
- DOI
- 10.2337/db15-0122
- language
- English
- LU publication?
- yes
- id
- e67b2fbf-eef6-4a67-af3f-09ab1c80efde (old id 8035204)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26395740?dopt=Abstract
- date added to LUP
- 2016-04-01 11:14:24
- date last changed
- 2024-04-22 06:25:10
@article{e67b2fbf-eef6-4a67-af3f-09ab1c80efde, abstract = {{Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with extrapancreatic effects beyond glycemic control. Here we demonstrate unexpected effects of GIP signaling in the vasculature. GIP induces the expression of the pro-atherogenic cytokine osteopontin (OPN) in mouse arteries, via local release of endothelin-1 (ET-1) and activation of cAMP response element binding protein (CREB). Infusion of GIP increases plasma OPN levels in healthy individuals. Plasma ET-1 and OPN levels are positively correlated in patients with critical limb ischemia. Fasting GIP levels are higher in individuals with a history of cardiovascular disease (myocardial infarction, stroke) when compared to controls. GIP receptor (GIPR) and OPN mRNA levels are higher in carotid endarterectomies from patients with symptoms (stroke, transient ischemic attacks, amaurosis fugax) than in asymptomatic patients; and expression associates to parameters characteristic of unstable and inflammatory plaques (increased lipid accumulation, macrophage infiltration and reduced smooth muscle cell content). While GIPR expression is predominantly endothelial in healthy arteries from human, mouse, rat and pig; remarkable up-regulation is observed in endothelial and smooth muscle cells upon culture conditions yielding a "vascular disease-like" phenotype. Moreover, a common variant rs10423928 in the GIPR gene associated with increased risk of stroke in type 2 diabetes patients.}}, author = {{Berglund, Lisa and Lyssenko, Valeriya and Ladenvall, Claes and Kotova, Olga and Edsfeldt, Andreas and Pilgaard, Kasper and Alkayyali, Sami and Brøns, Charlotte and Forsblom, Carol and Jonsson, Anna and Zetterqvist, Anna and Nitulescu, Mihaela and Ruiz McDavitt, Christian and Dunér, Pontus and Stancáková, Alena and Kuusisto, Johanna and Ahlqvist, Emma and Lajer, Maria and Tarnow, Lise and Madsbad, Sten and Rossing, Peter and Kieffer, Timothy J and Melander, Olle and Orho-Melander, Marju and Nilsson, Peter and Groop, Per-Henrik and Vaag, Allan and Lindblad, Bengt and Gottsäter, Anders and Laakso, Markku and Goncalves, Isabel and Groop, Leif and Gomez, Maria}}, issn = {{1939-327X}}, language = {{eng}}, number = {{1}}, pages = {{239--254}}, publisher = {{American Diabetes Association Inc.}}, series = {{Diabetes}}, title = {{Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB.}}, url = {{https://lup.lub.lu.se/search/files/2498140/8056538.pdf}}, doi = {{10.2337/db15-0122}}, volume = {{65}}, year = {{2016}}, }